The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
HBV-Induced Immune Imbalance in the Development of HCC
Open accessAbstract
Chronic hepatitis B virus (HBV) infection is one of the high-risk factors for human HCC. Despite the integration of virus DNA and the oncoprotein HBx, chronic necroinflammation and hepatocellular regeneration account for hepatocarcinogenesis. As a noncytopathic virus, HBV is extensively recognized to mediate chronic liver damage through abnormal immune attack. However, the mechanisms driving HBV infection to HCC are poorly understood. During chronic HBV infection in humans, the adaptive immunity changes from immune tolerance to progressive immune activation, inactivation, reactivation and exhaustion, all of which may be the immune pathogenic factors for the development of HCC. Recently, the immunopathogenic mechanisms were described in mouse HBV-induced HCC models, which is absolutely dependent on the presence of HBV-specific T cell response and NK cell-derived IFN-γ, findings which are consistent with the observations from CHB and HCC patients. In this review, we summarize recent research progression on the HBV-specific CD8+T cells, and also CD4+T cells, B cells and non-specific immune cells and molecules underlying chronic HBV infection and eventual HCC development to demonstrate the pathogenesis of HBV-induced immune imbalance. Based on the progression, we discussed the potential of immune-based therapies and their challenges in the treatment of HBV-related HCC, including the checkpoint inhibition, genetically modified T cell transfer, therapeutic vaccines and metabolic modulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Thimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K. A., Purcell, R. H., & Chisari, F. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.68-76.2003 · Cited by 979
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Venook, A. P., Papandreou, C., Furuse, J., & Ladrón de Guevara, L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-05 · Cited by 965
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
Self-citationCharacterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.102 · Cited by 897 · cited 10×
“Additionally, the protective antibody production of B cells was also inhibited by Kupffer cell-derived IL-10 (72).”
BackgroundInfluentialReddy, K. R., Beavers, K. L., Hammond, S. P., Lim, J. K., & Falck-Ytter, Y. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.039 · Cited by 861
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Maini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., King, A. S., Herberg, J., Gilson, R., Alisa, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1269 · Cited by 800
Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo
Kakimi, K., Guidotti, L. G., Koezuka, Y., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.921 · Cited by 584
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Perrillo, R. P., Gish, R., & Falck-Ytter, Y. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.038 · Cited by 504
Fisicaro, P., Valdatta, C., Massari, M., Loggi, E., Biasini, E., Sacchelli, L., Cavallo, M. C., Silini, E. M., Andreone, P., Missale, G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.052 · Cited by 488
Adaptive immunity in HBV infection
Bertoletti, A., & Ferrari, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.026 · Cited by 483
Bertoletti, A., & Ferrari, C. (2012) · Gut · doi:10.1136/gutjnl-2011-301073 · Cited by 477
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
Ando, K., Moriyama, T., Guidotti, L. G., Wirth, S., Schreiber, R. D., Schlicht, H. J., Huang, S. N., & Chisari, F. V. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1541 · Cited by 449
Mason, W. S., Gill, U. S., Litwin, S., Zhou, Y., Peri, S., Pop, O., Hong, M. L. W., Naik, S., Quaglia, A., Bertoletti, A., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.012 · Cited by 449
Webster, G. J. M., Reignat, S., Brown, D., Ogg, G. S., Jones, L., Seneviratne, S. L., Williams, R., Dusheiko, G., & Bertoletti, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5707-5719.2004 · Cited by 387
Immune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
Lim, C. J., Lee, Y. H., Pan, L., Lai, L., Chua, C., Wasser, M., Lim, T. K. H., Yeong, J., Toh, H. C., Lee, S. Y., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316510 · Cited by 357
Fisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., Salerno, D., Boni, C., Massari, M., Cavallo, M. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4275 · Cited by 341
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Burton, A. R., Pallett, L. J., McCoy, L. E., Suveizdyte, K., Amin, O. E., Swadling, L., Alberts, E., Davidson, B. R., Kennedy, P. T. F., Gill, U. S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121960 · Cited by 330
Natural killer cells in liver disease
Tian, Z., Chen, Y., & Gao, B. (2013) · Hepatology · doi:10.1002/hep.26115 · Cited by 290
Self-citationSalimzadeh, L., Le Bert, N., Dutertre, C.-A., Gill, U. S., Newell, E. W., Frey, C., Hung, M., Novikov, N., Fletcher, S., Kennedy, P. T. F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121957 · Cited by 290
Peppa, D., Micco, L., Javaid, A., Kennedy, P. T. F., Schurich, A., Dunn, C., Pallant, C., Ellis, G., Khanna, P., Dusheiko, G., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001227 · Cited by 259
Kim, G.-A., Lim, Y.-S., Han, S., Choi, J., Shim, J. H., Kim, K. M., Lee, H. C., & Lee, Y. S. (2018) · Gut · doi:10.1136/gutjnl-2017-314904 · Cited by 258
Hepatitis B Virus–Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Park, J.-J., Wong, D. K., Wahed, A. S., Lee, W. M., Feld, J. J., Terrault, N., Khalili, M., Sterling, R. K., Kowdley, K. V., Bzowej, N., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.11.050 · Cited by 249
Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction
Yang, Y., Han, Q., Hou, Z., Zhang, C., Tian, Z., & Zhang, J. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.24 · Cited by 225
Self-citationEscaping High Viral Load Exhaustion
Reignat, S., Webster, G. J. M., Brown, D., Ogg, G. S., King, A., Seneviratne, S. L., Dusheiko, G., Williams, R., Maini, M. K., & Bertoletti, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011723 · Cited by 218
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Sun, C., Sun, H.-Y., Xiao, W.-H., Zhang, C., & Tian, Z.-G. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.41 · Cited by 213
Self-citationQasim, W., Brunetto, M., Gehring, A. J., Xue, S.-A., Schurich, A., Khakpoor, A., Zhan, H., Ciccorossi, P., Gilmour, K., Cavallone, D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.001 · Cited by 208
Fu, J., Zhang, Z., Zhou, L., Qi, Z., Xing, S., Lv, J., Shi, J., Fu, B., Liu, Z., Zhang, J.-Y., et al. (2013) · Hepatology · doi:10.1002/hep.26054 · Cited by 192
Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection
Gehring, A. J., & Protzer, U. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.10.032 · Cited by 185
T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes
Bohne, F., Chmielewski, M. M., Ebert, G., Wiegmann, K., Kürschner, T., Schulze, A., Urban, S., Krönke, M., Abken, H., & Protzer, U. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.002 · Cited by 183
Schuch, A., Salimi Alizei, E., Heim, K., Wieland, D., Kiraithe, M. M., Kemming, J., Llewellyn-Lacey, S., Sogukpinar, Ö., Ni, Y., Urban, S., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316641 · Cited by 180
Lau, G. K. K., Suri, D., Liang, R., Rigopoulou, E. I., Thomas, M. G., Mullerova, I., Nanji, A., Yuen, S., Williams, R., & Naoumov, N. V. (2002) · Gastroenterology · doi:10.1053/gast.2002.31887 · Cited by 179
NK cell education via nonclassical MHC and non-MHC ligands
He, Y., & Tian, Z. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.26 · Cited by 174
Self-citationCheng, X., Xia, Y., Serti, E., Block, P. D., Chung, M., Chayama, K., Rehermann, B., & Liang, T. J. (2017) · Hepatology · doi:10.1002/hep.29348 · Cited by 172
Tian, Y., Kuo, C.-F., Akbari, O., & Ou, J.-H. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.008 · Cited by 170
Li, H., Zhai, N., Wang, Z., Song, H., Yang, Y., Cui, A., Li, T., Wang, G., Niu, J., Crispe, I. N., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314098 · Cited by 161
Zhang, Q.-F., Yin, W.-W., Xia, Y., Yi, Y.-Y., He, Q.-F., Wang, X., Ren, H., & Zhang, D.-Z. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.28 · Cited by 161
Dysfunctional T cell metabolism in the tumor microenvironment
Beckermann, K. E., Dudzinski, S. O., & Rathmell, J. C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.003 · Cited by 159
Hoogeveen, R. C., Robidoux, M., Schwarz, T., Heydmann, L., Cheney, J. A., Kvistad, D., Aneja, J., Melgaço, J. G., Fernandes, C. A., Chung, R. T., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316644 · Cited by 145
Boni, C., Janssen, H. L. A., Rossi, M., Yoon, S. K., Vecchi, A. L., Barili, V., Yoshida, E. M., Trinh, H. N., Rodell, T. C., Laccabue, D., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.044 · Cited by 141
Li, M., Sun, R., Xu, L., Yin, W., Chen, Y., Zheng, X., Lian, Z., Wei, H., & Tian, Z. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500839 · Cited by 121
Self-citationInsights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
Rehermann, B., & Thimme, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.061 · Cited by 120
NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection
Maini, M. K., & Peppa, D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00057 · Cited by 117
Jin, Z., Sun, R., Wei, H., Gao, X., Chen, Y., & Tian, Z. (2010) · Hepatology · doi:10.1002/hep.23983 · Cited by 115
Self-citationmiR-146a negatively regulates NK cell functions via STAT1 signaling
Xu, D., Han, Q., Hou, Z., Zhang, C., & Zhang, J. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.113 · Cited by 114
Kong, X., Sun, R., Chen, Y., Wei, H., & Tian, Z. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303432 · Cited by 112
Self-citationSun, C., Lan, P., Han, Q., Huang, M., Zhang, Z., Xu, G., Song, J., Wang, J., Wei, H., Zhang, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03584-3 · Cited by 105
Self-citationZhu, L., Li, N., Li, F., Zhou, Z.-H., Sang, J., Chen, Y., Han, Q., Lv, Y., & Liu, Z. (2016) · Medicine · doi:10.1097/md.0000000000005749 · Cited by 103
Self-citationXu, L., Yin, W., Sun, R., Wei, H., & Tian, Z. (2014) · Hepatology · doi:10.1002/hep.26668 · Cited by 100
Self-citationJia, Y., Zeng, Z., Li, Y., Li, Z., Jin, L., Zhang, Z., Wang, L., & Wang, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117458 · Cited by 93
Cheng, Y., Zhu, Y. O., Becht, É., Aw, P. P. K., Chen, J., Poidinger, M., de Sessions, P. F., Hibberd, M. L., Bertoletti, A., Lim, S. G., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau6905 · Cited by 92
Zhang, H. H., Mei, M.-H., Fei, R., Liu, F., Wang, J. H., Liao, W., Qin, L. L., Wei, L., & Chen, H. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01269.x · Cited by 87
Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
Zong, L., Peng, H. C., Sun, C., Li, F., Zheng, M., Chen, Y., Wei, H., Sun, R., & Tian, Z. (2019) · Nature Communications · doi:10.1038/s41467-018-08096-8 · Cited by 86
Self-citationImmune Regulation by T Regulatory Cells in Hepatitis B Virus‐Related Inflammation and Cancer
Trehanpati, N., & Vyas, A. K. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12524 · Cited by 85
Koh, S., Kah, J., Tham, C. Y. L., Yang, N., Ceccarello, E., Chia, A., Chen, M., Khakpoor, A., Pavesi, A., Tan, A. T., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.027 · Cited by 85
Jacobi, F., Wild, K., Smits, M., Zoldan, K., Csernalabics, B., Flecken, T., Lang‐Meli, J., Ehrenmann, P., Emmerich, F., Hofmann, M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.016 · Cited by 79
Wang, L., Qiu, J., Yu, L., Hu, X., Zhao, P., & Jiang, Y. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0251-9 · Cited by 78
Nakamoto, Y., Kaneko, S., Fan, H. S., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020633 · Cited by 77
Xue, H., Lin, F., Tan, H., Zhu, Z.-Q., Zhang, Z.-Y., & Zhao, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154815 · Cited by 76
Boltjes, A., van Montfoort, N., Biesta, P. J., den Brouw, M. L. O., Kwekkeboom, J., van der Laan, L. J. W., Janssen, H. L. A., Boonstra, A., & Woltman, A. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu599 · Cited by 71
Wang, J., Zhao, W., Cheng, L., Guo, M., Li, D., Li, X., Tan, Y. J., Ma, S., Li, S., Yang, Y., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000927 · Cited by 70
Liver-resident NK cells and their potential functions
Peng, H. C., & Sun, R. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.72 · Cited by 70
Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology
Fioravanti, J., Lucia, P. D., Magini, D., Moalli, F., Boni, C., Benechet, A. P., Fumagalli, V., Inverso, D., Vecchi, A. L., Fiocchi, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.020 · Cited by 66
Li, X., Su, Y., Hua, X., Xie, C., Liu, J., Huang, Y., Zhou, L., Zhang, M., Li, X., & Gao, Z. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1167-y · Cited by 62
Chen, Y., Hao, X., Sun, R., Wei, H., & Tian, Z. (2018) · Hepatology · doi:10.1002/hep.30317 · Cited by 55
Self-citationWang, Q., Pan, W., Liu, Y., Luo, J., Zhu, D. Y., Lu, Y., Feng, X., Yang, X., Dittmer, U., Lu, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00219 · Cited by 54
Chen, T., Song, D., Min, Z., Wang, X., Gu, Y. X., Wei, B., Yao, J., Chen, K., Jiang, Z., Xie, H., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-14 · Cited by 49
Jiang, H., Li, L., Han, J., Sun, Z., Rong, Y., & Jin, Y. (2017) · DNA and Cell Biology · doi:10.1089/dna.2016.3571 · Cited by 47
NLR members in inflammation-associated carcinogenesis
Zhu, H., & Cao, X. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.14 · Cited by 47
Zhou, Z., Tong, D., Guan, J., Tan, H.-W., Zhao, L.-D., Zhu, Y., Yao, J., Yang, J., & Zhang, Z. (2016) · Europe PMC (PubMed Central) · Cited by 44
Chen, M., Hu, P., Peng, H. C., Zeng, W.-Q., Shi, X., Yu, L., Hu, H., Zhang, D., & Ren, H. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9678-z · Cited by 43
Hou, X., Hao, X., Zheng, M., Xu, C., Wang, J., Zhou, R., & Tian, Z. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.111 · Cited by 41
Self-citationWisskirchen, K., Kai, M., Schreiber, S., Asen, T., Weigand, L., Dargel, C., Witter, K., Kieback, E., Sprinzl, M. F., Uckert, W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182936 · Cited by 41
Wu, L., Peng, W., Wu, H., Miaw, S., Yeh, S., Yang, H., Liao, P.-H., Lin, J., Chen, Y., Hong, Y., et al. (2019) · Hepatology · doi:10.1002/hep.30510 · Cited by 40
Self-citationTIM-3 as a marker of exhaustion in CD8+ T cells of active chronic hepatitis B patients
Mohammadizad, H., Shahbazi, M., Roushan, M. R. H., Soltanzadeh-Yamchi, M., & Mohammadnia‐Afrouzi, M. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.01.026 · Cited by 32
Xu, R., Lin, F., He, J., Jin, L., Zhang, J., Fu, J., Liu, H., Wang, S., Zhang, Z., & Wang, F. (2012) · Immunology · doi:10.1111/imm.12024 · Cited by 29
Chang, K., Traum, D., Park, J., Ho, S., Ojiro, K., Wong, D., Wahed, A. S., Terrault, N. A., Khalili, M., Sterling, R. K., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007715 · Cited by 29
Attallah, A. M., El-Far, M., Zahran, F. M., Shiha, G. E.-S., Farid, K., Omran, M. M., Abdelrazek, M. A., Attallah, A. A., Elbeeh, A., El-Hosiny, R. M., et al. (2016) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2016.1179646 · Cited by 28
Musa, J., Li, J., & Grünewald, T. G. P. (2018) · The Journal of Pathology · doi:10.1002/path.5169 · Cited by 20
Liu, Y., Li, L., Liu, J., She, W., Shi, J., Li, J., Wang, J., & Jiang, W. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.001 · Cited by 19
Humoral immunity, the underestimated player in hepatitis B
Zhang, S., Zhao, J., & Zhang, Z. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.132 · Cited by 19
Su, I., Hsieh, W., Tsai, H., & Wu, H. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2012.10.08 · Cited by 14
Zhang, G.-L., Zhang, T., Zhao, Q., Xie, C., Lin, C., & Gao, Z. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s184809 · Cited by 14
CD4+CD25+ regulatory T-cells: a potential target for treating patients with chronic HBV infection
Yang, J., & Li, L. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.67 · Cited by 6
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Self-citationPotential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Li, Y., Zhang, C., Jiang, A., Lin, A., Liu, Z., Cheng, X., Wang, W., Cheng, Q., Zhang, J., Wei, T., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05104-y · Cited by 105
Metadata
- Authors
- Chen, Y., & Tian, Z.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-08-27
- Volume
- 10
- Pages
- 2048-2048
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2967454885
- Cited by
- 270
- References
- 93
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.